Cargando…
In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases
To offer more tailored treatment to individual patients with squamous cell carcinoma of the vulva, more accurate prediction of lymph node metastases is required. As p53 and mdm2 are genes known to be involved in the development of other tumours, we studied expression of p53 and mdm2 in carcinogenesi...
Autores principales: | Emanuels, A G, Koudstaal, J, Burger, M P M, Hollema, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363016/ https://www.ncbi.nlm.nih.gov/pubmed/10389975 http://dx.doi.org/10.1038/sj.bjc.6690318 |
Ejemplares similares
-
Odontogenic keratocyst: Analysis of recurrence by AgNOR, p53 and MDM2 profiling
por: Chandrashekar, Chetana, et al.
Publicado: (2020) -
Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019) -
Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016) -
Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
por: Kakeji, Y., et al.
Publicado: (1993) -
Neither Angel nor Beast
por: Coleman, Francis
Publicado: (2013)